Skip to main content
. 2019 May 12;10(9):1985–1990. doi: 10.7150/jca.30131

Figure 1.

Figure 1

Cumulative incidence of intracranial progression using competing risks regression analysis in patients treated with upfront RT and epidermal growth factor receptor-TKI.